US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Diphenhydramine HCl oral solution

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0121-0978-10 D-1101-2022
Class II · Moderate risk Terminated

Verapamil HCL

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 04094-011-01 D-1100-2022
Class II · Moderate risk Terminated

Thrombin JMI

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 60793-215-05 D-1099-2022
Class II · Moderate risk Terminated

Epinephrine

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 04094-933-01 D-1098-2022
Class II · Moderate risk Terminated

Depo-Medrol

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0009-3475-01 D-1097-2022
Class II · Moderate risk Terminated

Depo-Medrol

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0009-3073-03 D-1096-2022
Class II · Moderate risk Terminated

Bupivacaine Hydrochloride

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0409-1163-01 D-1095-2022
Class II · Moderate risk Terminated

Labetalol Hydrochloride Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 49884-122-01 D-1094-2022
Class II · Moderate risk Terminated

Prazosin Hydrochloride Capsules

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0378-1101-01 D-1093-2022
Class II · Moderate risk Terminated

Loperamide Hydrochloride capsules

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0378-2100-01 D-1092-2022
Class II · Moderate risk Terminated

Duraclon

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 67457-218-10 D-1091-2022
Class II · Moderate risk Terminated

Proventil HFA

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0085-1132-04 D-1090-2022
Class II · Moderate risk Terminated

Celestone Soluspan

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0085-4320-01 D-1089-2022
Class II · Moderate risk Terminated

Levofloxacin Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-6352-61 D-1088-2022
Class II · Moderate risk Terminated

Kinevac

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0270-0556-15 D-1087-2022
Class II · Moderate risk Terminated

Gastrografin

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0270-0445-35 D-1086-2022
Class II · Moderate risk Terminated

E-Z-Gas II

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0270-9020-01 D-1085-2022
Class II · Moderate risk Terminated

E-Z-Hd

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 32909-764-01 D-1084-2022
Class II · Moderate risk Terminated

Transderm Scop

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 10019-553-03 D-1083-2022
Class II · Moderate risk Terminated

Recothrom Thrombin Topical

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0338-0322-01 D-1082-2022
Class II · Moderate risk Terminated

Revonto

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 78670-003-67 D-1081-2022
Class II · Moderate risk Terminated

Revonto

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 27505-003-67 D-1080-2022
Class II · Moderate risk Terminated

Vecuronium Bromide for Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0703-2914-03 D-1079-2022
Class II · Moderate risk Terminated

Propofol Injectable Emulsion

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0591-2136-95 D-1078-2022
Class II · Moderate risk Terminated

Propofol Injectable Emulsion

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 00591-2136-51 D-1077-2022